BUY Dr. Lal Path Labs Ltd. — Kunal Saraogi
byKunal SaraogiHorizon: NA (inferred Intraday)16 Sept 2026, 9:27 am ISTvia Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·16 Sept · today
Indian Diagnostic Giants Post Strong Q1 FY27 Growth Amid Stable Pricing
NewsGoogle News·13 Sept · 3d ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dr. Lal Path Labs
- BUY — Shrikant Chouhan, Kotak Securities5 Nov 2026 · ~2 weeks · target ₹2,150 · SL hit
- SELL — Citigroup5 Nov 2026 · ~1 year · target ₹1,750 · Active
- BUY — Citigroup5 Nov 2026 · ~1 year · target ₹2,380 · Active
- SELL — Goldman Sachs5 Nov 2026 · ~1 year · target ₹1,750 · Active
- BUY — Ashish Kyal, Waves Strategy Advisors4 Nov 2026 · ~1 year · target ₹2,100 · Active
More from Kunal Saraogi
- BUY Shilpa Medicare6 Nov 2026 · ~1 year · target ₹1,160 · Active
- BUY AstraZeneca Pharma India6 Nov 2026 · ~1 year · target ₹8,800 · Active
- BUY BSE6 Nov 2026 · ~1 year · target ₹3,950 · Active
- BUY KPIT Technologies6 Nov 2026 · ~2 weeks · target ₹600 · Active
- BUY The Jammu & Kashmir Bank5 Nov 2026 · ~1 year · target ₹170 · Active

